Treating persistent atrial fibrillation is crucial to restore heart function and prevent stroke
Atrial fibrillation (A-fib) is the most common arrhythmia in adults — more than 8 million Americans have some classification of A-fib. Of those, researchers estimate about 70% have either persistent A-fib or long-standing persistent A-fib. […]
View moreNow recruiting patients for minimally invasive heart failure treatment
Heart failure centers are accepting patients for a clinical trial of a minimally invasive therapy for heart patients with reduced ejection fraction. Norton Heart & Vascular Institute is the only site in Kentucky or Indiana [...]
View moreCardiac or noncardiac chest pain? Guidelines for diagnosing chest pain symptoms
Diagnosing chest pain symptoms is a common occurrence in the primary care setting. Approximately 1% of all visits to primary care are related to chest pain, but rarely are these visits due to an acute […]
View morePostpartum cardiovascular disease makes pregnancy history a critical part of evaluating patients
Patients who have been pregnant and especially those who had complicated pregnancies are at higher risk for cardiovascular disease, but the condition typically arises 10 or 15 years after the pregnancy. Patients are screened months […]
View moreEvaluating chest pain with anatomic or functional testing: New guidance for decision making
A heavyset, 51-year-old truck driver with a history of hypertension presented at Norton Heart & Vascular Institute with four months of intermittent, sharp, substernal chest pain that was exacerbated by activity and becoming increasingly frequent. […]
View moreManaging atrial fibrillation in the primary care setting
Atrial fibrillation, or A-fib, is an increasingly common chronic condition seen in the primary care setting. Management is multifaceted and requires a team-based approach. Risk for A-fib increases with age and is greater if there [...]
View moreComparing substrate mapping techniques for ventricular tachycardia
Different substrate mapping techniques are available to identify myocardial sites for catheter ablation in ventricular tachycardia (VT) patients. A recent study has for the first time looked at how well they work compared with one […]
View moreKeith A. McLean, M.D., cardiologist, joins Norton King’s Daughters’ Health in Madison, Indiana
Norton Heart & Vascular Institute welcomes Keith A. McLean, M.D., cardiologist, to Norton King’s Daughters’ Health in Madison, Indiana. The office is located in the Norton King’s Daughters’ Health Downtown Medical Building at 630 N. […]
View moreKevin Graham, M.D., joins Norton Heart & Vascular Institute Structural Heart Program
Kevin A. Graham, M.D., a cardiothoracic surgeon, has joined Norton Heart & Vascular Institute. Dr. Graham, who earned his medical degree from Indiana University, Indianapolis, and completed his residency there, has been practicing in Illinois. […]
View moreIschemic heart disease in women may not show up on standard tests
Ischemic heart disease in women can lead to a heart attack, but this risk may go unnoticed. This is because a patient’s diagnostic coronary angiogram shows “clear” arteries. “When diagnosing women for ischemic heart disease, [...]
View moreBorderline hypertension poses myocardial dysfunction risks
Borderline hypertension or subclinical hypertension is a substrate for myocardial dysfunction, and patients can go for a long time with hypertension that isn’t clinically recognized, according to a heart failure specialist at Norton Heart & […]
View moreHypertension in women and its consequences
The risks and consequences of hypertension in women differ from those in men and change throughout women’s lifetimes. Overall, hypertension in women is less prevalent than in men until age 60 and becomes more prevalent […]
View more